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Summary
Cancer is caused by genetic damage to DNA, this mutant cell then grows
in an uncontrolled manner in the organism. Breast cancer is a one of most
common cancers among women. Early detection of breast cancer is the most
important way to reduce the mortality rate. Impedance measure is one of the
methods for breast cancer detection.
Apoptosis is programmed cell death and plays an essential role in
protection of both tissues and organisms. There are many ways to detect
apoptosis such as flow cytometry of PI stained cells, caspase assays and
impedance measurements.
The aim of this project is to use cell impedance system (CIS) to ask
whether breast cancer cell lines and a normal breast cell line can be
distinguished. Furthermore, whether cells undergoing apoptosis in response to
the chemotherapy reagent Etoposide can be identified using CIS.
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11 Introduction
1.1 Cancer
Cancer arises from normal cells. It is an accumulation of genetic errors
and genetic damages in cells (King, 2000). The cell’s fate to develop cancer is
dependent upon its exposure to DNA damaging factors, both endogenous
(oxygen species etc.) and exogenous (X-rays, some chemicals and viruses etc.)
and responses to DNA damage (Lutz and Fekete, 1996; Weinberg, 1998;
Kastan and Bartek, 2004).
The possibility of tumour development is reduced by the efficient repair of
DNA damage. However, genomic abnormalities will be increased by mutations
in DNA-damage response and checkpoint signalling pathways. The DNA
damages can make cells arrest or not to survive. But mutations in apoptosis
pathway or cell-cycle checkpoints will allow cell division with the abnormal
genes. This increases the cells proneness to cancer (Figure 1.1) (Kastan and
Bartek, 2004). The six hallmarks in cell physiology that can generate malignant
growth (Figure 1.2) will be discussed in detail in the following sections.
Figure 1.1 The progress of cancer development (Kastan and Bartek, 2004).
2Figure 1.2 Six hallmarks of cancer (Hanahan and Weinberg, 2000).
1.1.1 Self-sufficiency in growth signals
Normal cells need mitogenic growth signals, and then they can go into a
proliferative state from quiescence. Transmembrane receptors transmit these
signals into the cell. Mitogenic growth signals bind a specific group of signalling
molecules, which are growth factors, extracellular matrix components, and cell-
to-cell interaction molecules (Figure 1.3). In contrast with normal cells, cancer
cells are less dependent on exogenous growth signals (Hanahan and Weinberg,
2000) .
There are three common molecular strategies found in cancer that
increase growth signals.
3The change in extracellular growth signals: in normal cells, mitogenic
growth factors are made by cells to stimulate surrounding cell growth. However,
cancer cells are able to synthesize growth factors and response to these factors
creating a positive feedback signalling loop (Fedi, 1997). The ability of
manufacture of growth factors by cancer cells makes them less dependence on
other surrounding cells. The glioblastomas can produce platelet-derived growth
factor (PDGF) and sarcomas also are able to create tumour growth factor
α,TGFα, which are evident (Fedi et al., 1997).
The increase in transmembrane receptors: the transmembrane receptors
on cell surface which transfer the growth signals into the cell are overexpressed
in cancer cells. The receptor overexpression makes cancer cell very sensitive to
the growth factors. Cancer cells are responsive to the low level of growth factors
which would not trigger growth (Fedi, 1997). For example, the upregulation of
the epidermal GF receptor (EGF-R/erbB) in breast and brain tumours have
been identified (Slamon et al., 1987; Yarden and Ullrich, 1988).
The changes of intracellular circuits which are responsible for signal
transduction and action. The Ras proteins aid to transfer signals from outside to
inside cells (Alberts, 2008). The structure of Ras proteins changes in about
25%-30% of human cancers. The mutated Ras proteins remain in a hyperactive
state, which allows the mitogenic signals into cells without the stimulation by
normal upstream regulators (Medema and Bos, 1993; Rowinsky et al., 1999).
Therefore, cancer cells do not need to depend on mitogenic growth
signals (Hanahan and Weinberg, 2000).
4Figure 1.3 Transmembrane receptors transmit growth signals into the cell. Mitogenic growth
signals bind a specific group of signalling molecules and result in cell growing (Alberts, 2010).
1.1.2 Insensitivity to antigrowth signals
The function of multiple antigrowth signals in a normal tissue is to keep
cells in quiescence and tissue homeostasis. These signals contain both growth
inhibitors and cell-to-cell communication inhibitors in the extracellular matrix and
on the surface of surrounding cells. The transmembrane cell surface receptors
receive these growth-inhibitory signals and couple to intracellular signalling
circuits (Hanahan and Weinberg, 2000).
Antigrowth signals can stop cell proliferation in two ways. Cells are
forced to withdraw from the active proliferative state in the cell cycle to the
quiescence G0 phase. Alternatively, cell are induced to stop proliferative
potential permanently by being induced to move to postmitotic state (Hanahan
and Weinberg, 2000). Cancer cells have to avoid the antiproliferative signals if
they are to proliferate. The retinoblastoma protein (pRb) is missing in a children
eye tumor, Retinoblastoma (Alberts, 2010). pRb is an cell cycle progress
inhibitor (Alberts, 2002). E2F is a transcription factors governing the genes
which are key to the progress from G1 to S phase of the cell cycle. In a
Intracellular
signalling pathway
Cell growth
Signalling molecules
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5hypophosphorylated state, the pRb blocks cell growth by the function change of
E2F (Weinberg, 1998). In cancer cells, pRb is missing (Alberts, 2002), which
allows them going through the cell cycle inappropriately (Harrington, 2008).
1.1.3 Evading apoptosis
All cell types have the program of apoptosis in the form of latency.
Cancer cell population expanding is determined not only by the rate of cell
growth, but also the rate of cell death. Resistance to apoptosis is a hallmark of
all type of cancer (Hanahan and Weinberg, 2000).
The Caspase (cysteine-aspartic acid protease) family has 14 members
(Thornberry and Lazebnik, 1998), most of which contribute to apoptosis. The
effectors and executors of apoptosis such as Caspases are present but not
active. Once induced by some physiologic signals, the apoptotic program
develops by following steps. Cellular membrane, nuclear skeletons and the
chromosomes are all broken down and degraded. The nucleus is fragmented.
Finally, the apoptotic body is engulfed by nearby cells and disappears (Wyllie et
al., 1980).
The machinery of apoptosis is divided into two types: the sensors and
the effectors. The sensors are responsible for observing the extracellular and
intracellular conditions which is normal or abnormal. This impacts whether a cell
is going to survive or not. Many signals which induce apoptosis affect the
mitochondria. Mitochondria respond to proapoptotic signals with the release of
cytochrome C. The Bcl-2 family proteins function as either proapoptosis or
antiapoptosis, which have an effect on the mitochondria death signalling by the
cytochrome C release. When the DNA is damaged, the p53, the tumour
suppressor protein, is able to induce apoptosis by upregulating expression of
proapoptotic Bax. The Bax can stimulate the mitochondria to release the
cytochrome C, which can consequently activate the effectors of apoptosis -
Caspase 8 and 9 to co-operate with Caspase 3 leading apoptosis (Hanahan
and Weinberg, 2000).
Apoptosis will be introduced in detail in the ‘1.3 Apoptosis’ section.
61.1.4 Limitless replicative potential
All types of mammalian cells have cell-autonomous programs, which can
limit the multiplication. The cell-autonomous program works independently.
Cells stop doubling when the population expand to a certain number. However,
in cancer cells, this program is interrupted leading to a clone of cancer cells
expanding oversize, which constitutes a macroscopic (Hanahan and Weinberg,
2000).
Generating growth signals, insensitivity to antigrowth signals, and
resistance to apoptosis still cannot ensure vast cancer cells growth. Many of
types of cancer cells are immortalized in culture, which means cancer cells
acquired the limitless replicative potential in vivo during the proliferative
progression. The limitless replicative potential is crucial for the development to
the malignant state (Hayflick, 1997).
Furthermore, telomeres, thousands of repeats of a short 6bp sequence
element, at the end of chromosomes play a role as a counter in the cell
replication. During each phase of cell cycle, the 50-100bp of telomeric DNA is
missing from the end of the chromosome, because the DNA polymerases are
not able to entirely replicate the 3’ ends of DNA in S phase. Eventually, the
telomeres cannot protect the end of DNA leading the end-to-end chromosomal
fusions causing cell death (Counter et al., 1992). However, cancer cells can
upregulate expression of the telomerase to repair the telomeric DNA making the
telomeres maintained at a certain length, which permit cancer cell limitless
replication (Bryan et al., 1995; Bryan and Cech, 1999).
1.1.5 Sustained angiogenesis
The vasculature is responsible to supply the oxygen and nutrients, which
are very important to cell survival and function. The cells in a tissue are located
in within 100µm of a capillary blood vessel. Normally, angiogenesis is transitory
and under carefully control when a tissue has been formed (Bouck et al., 1996;
Hanahan and Folkman, 1996). Cancer cells must gain angiogenic ability which
allows them to get adequate oxygen and nutrients to develop (Alberts, 2008).
71.1.6 Invasion and metastasis
Many types of human cancer cells can invade tissue and go to distant
locations where they may establish new colonies. The metastasis of cancer
cells causes 90% human cancer death (Sporn, 1996). Some cancer cells lack
the cell-adhesion molecules. For example, cadherin , which is a protein
mediating cell-cell adhesion and holding normal cells at the place where they
should be (Alberts, 2010). So they can invade surrounding tissue and blood
vessels. When the invasive cancer cells cross the blood stream and reach a
new site, they escape from the vessels. At the new site, these cancer cells
survive and proliferate, depending on the interaction with other five hallmark
abilities (Hanahan and Weinberg, 2000; Alberts, 2008) (Figure 1.4).
Figure 1.4 The process of cancer cells metastasis (Alberts, 2008).
81.2 Breast cancer and representative cell lines
The normal breast is composed of lobules, ducts and stroma. Most
breast cancers start in the ducts or lobules (Sariego et al., 1995).Breast cancer
is one of the most common types of cancer of women in the world. In 2012, it is
predictable that more than 39,920 of patients will die from breast cancer and
there will be another 229,060 new cases in the US alone (Siegel et al., 2012).
The established risk factors of breast cancer are age, weight, childbearing and
family etc.. (Hoogstraten and McDivitt, 1981; Gibson et al., 2010) There is no
effective methods of avoiding breast cancer, but women can prevent the risk
factors for breast cancer such as smoking, alcohol drinking, diet etc.. Women in
high risk of breast cancer also can take medical or surgical preventive
measures (Vogel, 2000).
The mortality rate of breast cancer can be reduced by early detection. At
present, X-ray mammography is the most common technique used to detect
breast cancer (Elmore et al., 1998; Simonetti et al., 1998). But, the limitations
includes the reduced ability to detect cancer in a thick layer of breast tissue
(Zou and Guo, 2003). Another two techniques, ultrasound and magnetic
resonance imaging (MRI) also can be used to diagnose breast cancer. However,
breast MRI is very expensive and cannot be used to diagnose the patient under
a certain circumstances such as patient with a pacemaker (Edell and Eisen,
1999; NHS, 2011).
In this project, one type of human breast tissue cell line and two breast
cancer cells are used. The MCF-10A cell line is human epithelial breast cell line.
The MCF-7 is early-stage human breast adenocarcinoma cell line. The MDA-
MB-231 cell line is invasive human breast adenocarcinoma cell line (Han et al.,
2007).
1.3 Apoptosis
Apoptosis defines the morphological progression leading to controlled
cellular self-destruction (Kerr et al., 1972). The word, apoptosis, is a Greek word
meaning petals falling off from flowers and leaves dropping off from trees, which
are no longer needed (Fadeel and Orrenius, 2005). Apoptosis is strictly
9regulated program of cell death and plays a crucial role in the development and
the maintenance of multicellular organisms or cell populations in tissues (Leist
and Jaattela, 2001). Apoptosis is an established program in nearly all cells and
can be induced by many internal and external factors (Fadeel and Orrenius,
2005).
1.3.1 Morphological features of apoptosis
Apoptotic cells have many morphological changes. As described in
‘Evading apoptosis’ section, the cell shrinking indicates deformation and loose
contact to surrounding cells. The chromatin condenses along the nuclear
membrane. The plasma membrane blebs occur. In the end, the cell is
fragmented into apoptotic bodies containing cytosol. The neighbour cells engulf
the apoptotic bodies (Saraste and Pulkki, 2000).
1.3.2 Molecular mechanisms of apoptosis
1.3.3 Death signals activate signalling pathways
Apoptosis requires the interaction of numbers of factors. The apoptotic
signals encoded by genes are going to be activated by a death-inducing
stimulus (Ishizaki et al., 1995; Weil et al., 1996). A lot of stimuli from intracellular
or extracellular can trigger apoptosis such as, DNA damage due to faults in
DNA repair mechanisms, cytotoxic treatments or radiation treatment, lacking of
survival signals, or the death signal ligation of the cell surface receptor (Fadeel
and Orrenius, 2005).
1.3.4 Caspases are central executioners of apoptosis
In cells, caspases are in the form of procaspases, which are inactive
zymogens. The proapoptotic caspases is classified into two groups: initiator
caspases such as procaspases-2, -8, -9 and -10, and executioner caspase such
as procaspases-3, -6 and -7. The initiator caspases contain death effector
domains (DED) for example procaspases -8 and -10, or caspase recruitment
domains (CARD) such as procaspase-9 and procaspase-2 (Denault and
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Salvesen, 2002). The activated initiator caspases are response to either
extrinsic apoptosis pathways or intrinsic apoptosis pathways as below.
In extrinsic apoptosis pathways, the death-inducing stimuli from outside
of the cell are ligation to the death receptor on cell membrane; and then the
death receptor recruits adaptor molecules by containing cytoplasmic death
domains (DD). The adaptors also contain DEDs which can recruit procaspase-8
by its own death effector domains (DEDs). Procaspse-8 is activated by
proteolytic reaction and forms the active caspase-8, a heterotetramer of two
large and two small subunits. The caspse-8 proteolytically cleaves and activates
other caspases for the execution of apoptosis (Figure 1.5) (Denault and
Salvesen, 2002).
Figure 1.5 In extrinsic apoptosis pathways (Denault and Salvesen, 2002).
In intrinsic apoptosis pathways, the release of cytochrome C from inner
membrane of mitochondria is triggered by apoptotic stimulus. Apoptosome is
formed when cytochrome C is released from the mitochondria. Apoptotic
protease activating factor 1 (Apaf-1) is the core of the apoptosome. The
cytochrome C and Apaf-1 protein forms a heptameric, wheel-like structure
which is apoptosome. Apoptosome can activate initiator protocaspase such as
procaspase-9 by binding them to a heptamer (Figure 1.6) (Acehan et al., 2002).
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Once the initiator caspases have been activated, they can proteolytically
activate the executioner caspase including caspases-3, -6 and -7 resulting in
apoptosis (Earnshaw et al., 1999).
In some cells, the intrinsic pathway is needed to amplify the extrinsic
pathway of apoptotic signals (Alberts, 2008). Caspase 8 can mediate the
cleavage of the proapoptotic protein Bid, one of the Bcl-2 family members,
which results in the release of cytochrome C from mitochondria (Fadeel et al.,
1999; Wang and Youle, 2009). So there are sufficient signals to trigger
apoptosis.
Figure 1.6 In intrinsic apoptosis pathways (Acehan et al., 2002).
1.3.5 p53
Tumour suppressor protein p53 is encoded by tumour suppressor gene
p53. The p53 is able to response to the irreparable DNA damage etc. (Alberts,
2008). p53 also can induce the expression of proapoptotic proteins such as Bax,
Apaf-1 etc., and inhabit the expression of antiapoptotic proteins Bcl-2 (Wu et al.,
2001; Hoffman et al., 2002; Vousden and Lu, 2002). Moreover, p53 protein can
12
translocate to the mitochondria and suppress antiapoptotic gene Bcl-XL release
of cytochrome C (Mihara et al., 2003).
1.3.6 Methods of cell apoptosis detection
Apoptosis occurs by complicated signalling cascade. When, where and
what kind of proteins involved are tightly regulated. It is important to detect the
initiators, the effectors and executioners at right time point. Moreover, multi
ways of detection can be used to observe apoptosis. For example, use a first
assay to detect early apoptosis and a second one to observe the late apoptosis.
Two ways based on different principles can confirm apoptosis (Watanabe et al.,
2002; Otsuki et al., 2003; Elmore, 2007).
Early apoptosis detection
AlamarBlue Assay
AlamarBlue is a real-time and nontoxic assay to indicate the viability and
cytotoxicity of cells. The damaged and nonviable cells generate lower intensity
of fluorescence than healthy cells (LifeTechnologies, 2012). AlamerBlue will be
introduced in detail in ‘5.3 Using AlamarBlue assay to indicate apoptosis’
section.
Caspase Assay
Caspase assay is caspase substrates. Caspases such as caspase-3 can
cleave the non-fluorescent substrates to generate fluorescent amino acid
peptides. The intensity of fluorescence indicates the quantity of caspases
(Millipore, 2012).
Phosphatidylserine (PS)
Phosphatidylserine (PS) transfer from the inner cell membrane to the
outside of cell membrane in early apoptosis. AnnexinV is a protein can
specifically bind with the exposed PS in outer membrane, which can be
detected by a fluorescent microscopy or a fluoremeter (Kylarova et al., 2002).
Glutathione (GSH)
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Glutathione (GSH) is very important in cells as it can remove the toxic
oxides within the cells. When the level of mitochondrial GSH reduces, it will lead
to the cytochrome C transferring from the inner membrane of mitochondria to
the cytoplasm. Then, apoptosis will be triggered (Circu et al., 2008). Therefore,
GSH could be a target to detect early apoptosis.
Cytochrome C
Cytochrome C plays a key role in apoptosis. As described before, it
exists in the inner membrane of mitochondria. The apoptotic stimuli will make it
released outside mitochondria. Then caspase cascade reaction will start. So
using antibody to mark the position of cytochrome C can determine apoptosis
(Terauchi et al., 2005).
Mitochondrial membrane potential
Mitochondrial membrane potential changes in early apoptosis, when the
morphology of mitochondrial has not changed. The mitochondrial membrane
potential changes result in the alteration of the permeability. By using a cationic
dye which is very sensitive to the mitochondrial permeability changes, cell
undergoing apoptosis can be detected by fluorescent microscopy or by flow
cytometry (Scarlett et al., 2000).
Late apoptosis detection
PI staining
Propidium iodide (PI) can intercalate DNA double-stranded becoming
strongly fluorescent. As PI cannot pass through live cell membrane, it only can
stain dead or dying cells. PI can be detected by a fluorescence microscopy and
flow cytometry and indicate the DNA content in cell cycle (LifeTechnologies,
2012). So apoptotic cells can be differentiated from the normal cells.
TUNEL
In late apoptosis, endonuclease cut nuclear DNA into a large number of
180-200 bp in length of DNA fragments. Terminal deoxynucleotidyl transferase
mediated dUTP nick end labelling is a method to detect DNA fragments through
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labelling the terminal end of nucleic acids. The nicks of DNA can be identified
by the terminal deoxynucleotidyl transferase which will catalyse the addition of
dUTPs labelled with a marker (Kylarova et al., 2002).
Telomere length detection
Telomere is a thousand repeats of 6 bp TTAGGG at the end of
chromosome. In each time of cell division, chromosome telomeres will shorten.
Without the protection of telomeres, chromosome becomes unstable and the
chromosomal ends will get fusion. This will make cells having a limited life span.
So telomere length can indicate senescence or apoptosis (Millipore, 2005;
Bermudez et al., 2006).
1.3.7 Apoptosis and disease
In the human body, thousands of cells are generated by mitosis and a
similar number of cells undergo apoptosis in every second for maintenance of
homeostasis and regulation of immune cell selection (Fadeel et al., 1999).
Dysregulation of apoptosis will lead to various disease such as cancer, due to
cell accumulation, resistance to therapy (Reed, 2002). Cancer cells resist to the
chemotherapeutic drugs and irradiation because of its apoptosis resistance
(Fulda and Debatin, 2004).
1.4 Bio-impedance techniques for breast cancer detection
1.4.1 What is bio-impedance
Bio impedance is a measure of how much cells or tissue impede the flow
of electric current. Impedance is measured in ohms, symbol Ω (Dean et al.,
2008). Bio-impedance varies with the cell structure. This can be used to
distinguish normal tissue from cancerous tissue in various organs, including
breast, cervix, skin, bladder and prostate (Halter et al., 2007). The cellular
components, the diameters, and the cellular internal structure determine the
electrical properties of cells over different frequency ranges. So, different
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cellular structures of cells will have characteristic impedance spectra (Halter et
al., 2007).
1.4.2 The application of bio-impedance in breast cancer
The different bio-impedance of tissue depends on their structures. The
cell membrane, cytoplasm etc. are capacitive and resistive (Zou and Guo, 2003).
In the 1920s, Frick and Morse firstly found the significant difference of
capacitance between breast cancers and normal tissues in various types of
breast tissue (Fricke H, 1926). This was the first time that bio-impedance was
applied to biology (Zou and Guo, 2003).
From 1920, various in vitro impedance measurement results have shown
significant differences between malignant tumours and breast tissues (Zou and
Guo, 2003). In contrast to surrounding normal tissues, malignant tumours
displayed lower impedance (Jossinet et al., 1985). The electrical properties of
malignant tissue changes because there is an increase in cellular water and salt
contents which alters the membrane permeability, there is also changed
packing density, and orientation of cells (Scholz, 2000).
1.5 Bio-impedance of cells
As addressed before, bio-impedance can be used to distinguish tissue
and carcinoma in many organs (Halter et al., 2007). Also it has been widely
applied to measure the conditions of animal tissues in vivo and in vitro (Bauchot
et al., 2000; Kerner et al., 2002). Bio-impedance is a useful method to
determine the cellular changes quantitatively (McRae et al., 1999; Soley et al.,
2005). Bio-impedance of cells over a range of frequencies can estimate cell
population, the electric property of the cell membrane and the intercellular and
intracellular conductivity (Dean et al., 2008).
In addition, bio-impedance is a non-invasive diagnostic technique
(Gersing, 1998; Kerner et al., 2002). In 1998, it had been used to determine
whether a canine heart muscle and a porcine liver can recover or not from
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ischemia (Gersing, 1998). In 2002, the investigation of the bio-impedance of 26
women’s breasts was carried out by Kerner (Kerner et al., 2002). In 2005, the
growing yeast cells were observed using bio-impedance (Soley et al., 2005). In
2007 bio-impedance was used to distinguish normal and carcinoma prostate
tissue (Halter et al., 2007).
Bio-impedance can be applied to wider areas such as the food industry,
and other commercial uses (Spreekens and Stekelenburg, 1986; Varshney and
Li, 2008).
1.5.1 Electrical properties of cells
Ions in cells allow electrical conduction (Dean et al., 2008). In an electric
field, current flows due to the movement of ions in the medium and cells.
Different cells have their particular ionic content and mobility. This can be
characterised by a combination of cell conductivity, σ (Pethig, 1987; Dean et al.,
2008) and permittivity ε. Conductivity is a measure of the ability of a material 
conducting the electric current. Permittivity describes the ability of a material to
resist the electric current (Grimnes and Martinsen, 2008). Conductivity and
permittivity vary between different cells according to equation 1.1 (Pethig, 1987).
ߝ= ߝ௥ߝ଴ + ݆∗ ఙఠ (1.1)
Where: εr is relative permittivity due to different materials,
ε0 =8.85× 10−12 F/m, it is the vacuum permittivity,
σ = electrical conductivity, 
ω is angular frequency = 2 π f. f is frequency, 
j is complex number, ݆= √−1.
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Figure 1.7 Three dispersions of cells (Schwan, 1993; Grimnes and Martinsen, 2008).
The permittivity and conductivity are both are frequency dependent. With
the increasing frequency, permittivity falls, whilst conductivity increases. The
three dispersions vary with frequency according to the electric properties of the
cell suspensions (Schwan, 1957). According to Schwan’ theory, there are three
dispersion mechanisms α, β, γ of the electric properties of cell suspensions 
(Schwan, 1957)(Figure 1.7). The α-dispersion is significant over the frequency 
range of 10 Hz–10 kHz. This is influences the ions or intercellular factors
outside cells. From 0.1MHz to 10 MHz, the flow of current is able to pass
through the cell membrane and cytoplasm because the cell membrane acts as
a capacitor, which causes the β-dispersion to occur. β-dispersion is affected by 
the impedance changes of the cell membrane. When the frequency is between
100MHz to some GHz, γ-dispersion occurs due to the internal structure of the 
cells that is the nuclear envelope, membrane of organelles and water
concentration in each cell (Schwan, 1993; Tacconi et al., 2004; Grimnes and
Martinsen, 2008) (Table 1.1 ).
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Table 1.1 Dispersions of cells (Grimnes and Martinsen, 2008).
1.6 Aims of this project
This project aims to use the cell impedance system (CIS)
to distinguish breast cancer cell lines from a normal breast cell line;
to investigate whether undergoing apoptosis could be detected by CIS.
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2 Materials and methods
2.1 Cell culture
Jurkat 6 and DG75 cell lines were cultured in RPMI media (Invitrogen)
supplemented with 10% heat-inactivated fetal bovine serum, 2 mmol/L L-
glutamine, 100 IU/mL penicillin, 100 µg/mL streptomycin (Invitrogen). The cells
were maintained in an incubator at 37°C with 5% CO2. Cells were split 2 to 3
times every week. For storage, cells were frozen in freezing media which is
composed of 85% fetal bovine serum and 15% DMSO (Sigma).
Human breast cancer cell lines MDA-MB-231 and MDA-MB-7 (CLS-Cell
lines service, Germany), and human breast tissue cell line MCF-10A (American
Type Culture Collection, USA) were cultured in DMEM/F12 media (Invitrogen)
supplemented with 10% heat-inactivated fetal bovine serum, 2 mmol/L L-
glutamine, 100 IU/mL penicillin, 100 µg/mL streptomycin (Invitrogen), 20 ng/mL
epidermal growth factor (Invitrogen), 500 ng/mL hydrocortisone (Sigma), 100
ng/mL cholera toxin (Sigma) and 10 µg/mL bovine insulin (Sigma). The cells
were maintained in an incubator at 37°C with 5% CO2. Cells were split 2 to 3
times every week. For storage, cells were frozen in freezing media which is
composed of 85% fetal bovine serum and 15% DMSO (Sigma).
2.2 Cell viability measurement
To wash cells from the media, they were pelleted by centrifugation at
1300 rpm for 5 minutes and the supernatant was retained as conditioned media.
Cells were re-suspended in 4°C DPBS and pelleted as above. Then cells were
re-suspended in DPBS or DPBS with serum replacement, respectively. 1ml of
3X105 cells/ml cells was placed in each well of 12-well plate. At 0 minute, 30
minutes, 60 minutes and 120 minutes cells were counted. To count cells, 100ul
of cells were placed in a 1.5ml tube at 20°C, mixed with an equal volume of
Trypan Blue (Invitrogen) and vortexed. Then 10ul of cells were added to a
haemocytometer. The approximate number of cells was determined using a 16
square haemocytometer, under microscope. The white cells were alive the blue
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ones were dead. The number of live cells was recorded and the curves of
viability were drawn.
Cell viability was also measured by AlamarBlue assay (Invitrogen). A 96-
well plate contained cells at different densities of 0, 80, 400, 2000, 10000 and
50000 cells per 100µL and then incubated at 37°C and 5% CO2 for 24 hours.
10µL of AlamarBlue assay were added into each well. A fluorometer was used
to measure the fluorescent intensity of the plate at each time point.
2.3 Cell diameters measurement
Cells were in suspension placed into a 24-well plate. The Olympus
optical microscope with a DMK 31BF03 camera was used to observe cells at 10
times magnification. The camera was linked to a PC via an IEEE 1394 interface.
A software named SCIght was used to analyse cells, which can measure the
number of pixels between 2 points on the image. 50 µm is equal to 106 pixels;
hence, 1 pixel is equal to 0.47 µm. 50 cells of each cell lines were measured
without bias.
2.4 Fluorescent Activated Cell Sorting (FACS)
Etoposide was prepared at 10mg/ml in DMSO and added directly to the
cells in culture media to give a final concentration of 10µg/ml. Control cells
contained an equivalent volume of DMSO. Cells were incubated for 0h, 24h,
48h and 72h, washed with DPBS, fixed with 80% ethanol and kept at 4°C for 1
hour. Then ethanol was removed after cells were pelleted by centrifugation at
1300 rpm for 5 minutes. 1 ml Propidium Iodide (PI) Stain and 5ul RNase A were
added to a cell pellet and kept at 4°C for 1 hour. FACS CANTO flow cytometry
was used to analyse cells.
2.5 AlamarBlue assay detecting apoptosis
MCF-10A, MCF-7 and MDA-MB-231 cells were trypsinazed. Cells were
placed in a 96-well plate at the density of 2X105 cells/ well. After being added
10μL AlamarBlue (Invitrogen), the plate was incubated for 5 hours and then 
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measured fluorescent intensity by using fluorometer (Promega GloMax-Multi
Detection System).
2.6 Caspase assay detecting apoptosis
At 4h, 8h, 24h each time point, 1.5 X106 cells with Etoposide or with
DMSO were spun down and washed with DPBS. Then DPBS were removed
and cells pellet were frozen at -80°C. 1X107 cells/ml cells were lysed on ice, in
150µL Caspases Lysis Buffer with adding protease inhibitor cocktail. Cells were
vortexed and debris pelleted by centrifugation in a micro-centrifuge at 13000rpm
for 10 seconds. The supernatant containing the lysed cells was frozen at -80°C.
The assays were carried out in 96-well plate by mixing 50µl of cell lysate with
200µl of Caspase Reaction Buffer containing 5µg of the Ac-DEVD-AMC
Caspase-3 Fluorogenic Substrate. Controls were performed using 50µl of
Caspase Lysis Buffer. The plate were incubated at 37°C for 60 minutes and the
fluorescence produced by AMC release was visualized using a fluorometer with
an excitation wavelength of 380nm and an emission wavelength of 440nm.
Caspase Lysis Buffer
1 ml of 1 M Tris pH 7.5 (10 mM final)
10 ml of 100 mM NaH2PO4/Na2HPO4 pH 7.5 (10 mM final)
6.5 ml of 2M NaCl (130 mM final)
1 ml of 100% triton-x100 (1% final)
10 ml of 100 mM Na4P2O7 (10 mM final)
Add water to 100 ml and store at 4°C.
Caspase Reaction Buffer
10 ml of 200 mM Hepes, pH 7.5 (20 mM final)
20 ml of 50% glycerol (10 % final)
0.2 ml of 1 M DTT (2 mM final)
Add water to 100 ml and store at 4°C.
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2.7 Cell impedance measurement
Cells were in suspension and washed with DPBS. Cells were measured
in 50% DPBS and 50% sterile water with 2% serum replacement at 25°C or
37°C. Before and after each measurement, viability, density testing and volume
fraction were measured. Each time, 180µL cells suspensions were loaded into
the chamber.
The cell impedance system was set up with using impedance analyser
Agilent 4194A controlled by a laptop through GPIB-USB cable for data
acquisition. The measurement device was plugged into Agilent 4194A directly
by four BNC connectors. Three breast cell lines were measured and compared
with conditions control.
2.8 Transmission electron micrographs
Preparation for TEM
Cells were pelleted in the culture media by centrifugation at 2000 rpm in
eppendorfs.
Fixation
0.1ml of 25% glutaraldehyde was added to each eppendorf. The
eppendorfs were rotated over night at room temperature
Rinsing and staining
The supernatants were removed and the pellets were washed with fresh
media. The eppendorfs were rotated for 10 minutes then the media was
removed, five times repeated. 1 ml of osmium tetroxide was added to each
eppendorf and left in a hood for 2 hours, then removed. The pellets were rinsed
with deionised water and kept in it for 20 minutes. The deionised water was
removed. These steps were repeated three times. The eppendorfs were kept
overnight in a 4°C cold room.
Dehydration
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The eppendorfs were taken out from the cold room. The deionised water
was removed. 1.5 ml of 50% ethanol were added into each eppendorf, left for
20 minutes, and removed. 1.5 ml of 75% ethanol were added into each
eppendorf, left for 20 minutes, and removed. 1.5 ml of absolute ethanol were
added into each eppendorf, left for 20 minutes, and removed. This step was
three times repeated. 1.5 ml of Propylene oxide (PO) were added into each
eppendorf, left for 20 minutes, and removed. 0.75ml of PO and resin were
added into each eppendorf (PO: resin=50:50). The eppendorfs were rotated
overnight at room temperature.
The mixture of PO and resin was removed then 1 ml of resin was added
into each eppendorf. The eppendorfs were rotated overnight at room
temperature.
The resin was removed. 1ml of fresh resin was added into each
eppendorf. The eppendorfs were rotated overnight at a 4°C cold room.
Section and photographing
Thanks Dr Julian Thorpe for the TEM section and TEM photographing.
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3 Testing conditions design and the performance
3.1 Introduction
The study of applying Cell Impedance System (CIS) for distinguishing
cells will be discussed in the following three chapters. This chapter aims to
investigate the testing conditions and their performance. Chapter Four will ask
whether different pathologies of breast cancer cells can be differentiated from
breast tissue cells by Cell Impedance System (CIS). Moreover, Chapter Five
will focus on whether cells undergoing apoptosis and normal growing cells also
can be distinguished by CIS.
Breast tissue cells and breast cancer cells are adherent cells growing in
DMEM/F12 media with fetal bovine serum and other supplements as discussed
in Chapter Two. The impedance measurement device is a cylindrical chamber
into which cell suspension is loaded. Cells will be kept in suspension during the
process of impedance measurement. Fetal bovine serum (FBS) is the portion of
plasma remaining after centrifugation of blood. It is variable from batch to batch
in composition. Culture media has complex supplements including FBS, which
may influence impedance measurements and repeatability. Dulbecco’s
Phosphate Buffered Saline (DPBS) will be used as an alternative to culture
media. DPBS, one kind of isotonic solution, is widely used in washing cells and
able to maintain cell tonicity and survival for a limited period of time. The serum
replacement is also designed to aid cell viability, which may lengthen survival
time in DPBS. Moreover, in the process of impedance measurement, cells will
be taken out from the incubator and cell impedance will be measured at the
room temperature of approximately 20°C. Each cell line will take not more than
120 minutes to be measured. So these conditions all need to be tested before
the impedance measurement.
3.2 Cell survival in DPBS with serum replacement
To question whether cells are healthy while cells are in the conditions,
DG 75 and Jurkat 6 cells viability will be evaluated in DPBS at 4°C, 20°C and
37°C to find out which is the best suitable temperature. 4°C is used for slowing
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down cell division and preventing over-heating as current flows will generate
heat when they pass through electrodes. 20°C and 37°C are the temperatures
for room temperature and cell native growing environment, respectively. The
serum replacement is less complex than FBS and designed for long-term
growth of human cells and only contains human serum albumin, human
transferrin, and human recombinant insulin (Sigma-Aldrich, 2010). These
proteins play roles as growth factors in cell culture. So the serum replacement
may aid cell survival and is used to replace fetal bovine serum (FBS) as it is
more reproducible.
Cell suspensions in DPBS with or without the serum replacement were
placed in a 24-well plate, incubated for 0~120 minutes and live cells were
counted with a haemocytometer. Figure 3.1 shows that in DPBS DG 75 cell
population dramatically reduced in the first 30 minutes at indicated three
different temperatures. And also Figure 3.2 shows Jurkat 6 cell in DPBS nearly
died out within 120 minutes. Compared with cells without serum replacement,
cell densities of DG 75 and Jurkat 6 cells in DPBS with serum replacement
remained stable over 120 minutes at three different temperatures. At 20°C,
room temperature, cell survival was more stable than at other two temperatures.
With aid of serum replacement, cells can survive at least 120 minutes. So the
optimal conditions are room temperature, 20°C, and cells in DPBS with serum
replacement.
During the measurement of impedance, cells will be exposed in air rather
than at 5% CO2. So whether cells can survive exposure in air also needs to be
measured. Cells suspension in DPBS with serum replacement were placed in
24-well plate and incubated at 20°C with covering or not. Figure 3.3 shows that
covering or not did not affect the viability of DG 75 and Jurkat 6 cells. After 120
minutes, cells densities were the same as at the beginning. So DG 75 and
Jurkat 6 cells can survive in DPBS with serum replacement without covering for
120 minutes.
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Figure 3.1 DG75 viability test at different temperature with or without serum replacement.
Lymphoma cells DG75 were incubated in DPBS or DPBS with serum replacement for 0~120
minutes at the indicated temperature. Cells were dyed with Trypan Blue assay. The number of
viable cells was determined using a haemocytometer in triplicate from three wells and error bars
represent standard deviation.
0.0
2.0
4.0
6.0
8.0
0min 30min 60min 120min
C
el
lD
en
si
ty
(×
10
5 c
el
ls
/m
l)
4°C
0.0
2.0
4.0
6.0
8.0
0min 30min 60min 120min
C
el
lD
en
si
ty
(×
10
5 c
el
ls
/m
l)
20°C
0.0
2.0
4.0
6.0
8.0
0min 30min 60min 120min
C
el
lD
en
si
ty
(×
10
5 c
el
ls
/m
l)
Time
37°C
DPBS DPBS with Serum Replacement
A
B
C
27
Figure 3.2 Jurkat 6 viability test at different temperature with or without serum replacement.
Lymphoma cells Jurkat 6 were incubated in DPBS or DPBS with serum replacement for 0~120
minutes at the indicated temperature. Cells were dyed with Trypan Blue assay. The number of
viable cells was determined using a haemocytometer in triplicate from three wells and error bars
represent standard deviation.
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Figure 3.3 DG 75 and Jurkat 6 viability test with or without covering. Lymphoma cells DG75 and
Jurkat 6 were incubated in DPBS with serum replacement with covering or without covering for
0~120 minutes at 20°C. Cells were dyed with Trypan Blue assay. The number of viable cells
was determined using a haemocytometer in triplicate from three wells and error bars represent
standard deviation.
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Figure 3.4 MCF-10A viability test with or without covering. Breast tissue cells MCF-10A were
incubated in DPBS or DPBS with serum replacement for 0~120 minutes at 20°C. The number of
viable cells was determined in triplicate from three wells and error bars represent standard
deviation.
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Figure 3.5 MCF-7 viability test with or without covering. Early breast cancer cells MCF-7 were
incubated in DPBS or DPBS with serum replacement for 0~120 minutes at 20°C Cells were
dyed with Trypan Blue assay. The number of viable cells was determined using a
haemocytometer in triplicate from three wells and error bars represent standard deviation.
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Figure 3.6 MDA-MB-231 viability test with or without covering. Invasive breast cancer cells
MDA-MB-231 were incubated in DPBS or DPBS with serum replacement for 0~120 minutes at
20°C. Cells were dyed with Trypan Blue assay. The number of viable cells was determined
using a haemocytometer in triplicate from three wells and error bars represent standard
deviation.
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Human breast cell line MCF-10A and human breast cancer cell lines
MCF-7, and MDA-MB-231, were placed in suspension in 24-well plates and
incubated at 20°C for 0~120 minutes conditions I found optimal for lymphoid
cells. Figure 3.4-Figure 3.6 show that in two hours time period, regardless of
covering or not, cells can survive in both DPBS or DPBS with serum
replacement.
3.3 Cell morphology
Human breast cell line MCF-10A and human breast cancer cell lines
MCF-7, and MDA-MB-231 can be differentiated by morphology. Cells were
cultured adhered to plastic dishes and photographed. Figure 3.7 shows the
morphology of three breast cell lines.
After trypsinization, cells were in suspension and photographed at the
indicated densities. Figure 3.8 demonstrate MCF-10A cells were quite uniform,
but there were variations on MCF-7 or MDA-MB-231 cells.
3.4 Differences in cell volume
In order to know the accurate impedance of cells, the total volume of
cells must be the same, but from the cell morphology photographs of breast
cancer cells and breast tissue cells, the diameters did not look the same. In
order to ask how variable the diameter is, after trypsinization, 50 cells of each
cell line were measured under microscope by using IC Imaging Control 3.0
software. Figure 3.9A displays that there is a great variation in diameters of
MDA-MB-231 cells and also variation in others. In Figure 3.9B, the size of error
bar shows that MCF-7 and MDA-MB-231 cells display greater variation than
others.
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Figure 3.7 Morphology of MCF-10A, MCF-7, and MDA-MB-231 cells. Cells were cultured
adhered to plastic dishes. Cells were plated at density of 2X105 cells/ml and photographed.
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Figure 3.8 Morphology of MCF-10A, MCF-7, and MDA-MB-231 cells in suspension. The three
breast cell lines were removed from culture plates by trypsinization and photographic images
taken. The density of the cells is 2X105 cells /ml.
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Figure 3.9 These three breast cell lines were removed from culture plates by trypsinization. The
diameters of 50 cells were measured in suspension. Figure A is the cell number at different
diameters. The X axis is the diameters of three cell lines and Y axis is the number being
measured. Figure B is the average diameter of each cell line.
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3.5 Cell survival in modified DPBS buffer
As described before, cells can survive up to 120 minutes in DPBS.
However, a problem is that DPBS is much more conductive than cells. The
impedance of cells at the density of 3~6X107 cells/ml cannot be observed in
DPBS. To solve this problem, deionised water which is non-conductive was
added into DPBS to reduce the conductivity. A series of modified buffers were
made with different volume ratio of deionised water and DPBS, which are from
10% DPBS with 90% deionised water with serum replacement to 50% DPBS
with 50% deionised water with serum replacement. Unfortunately, cells cannot
survive with less than 50% DPBS with 50% deionised water. Figure 3.10 shows
MCF-10A, MCF-7 and MDA-MB-231 cells can survive over 60 minutes in 50%
DPBS with 50% deionised water at 20°C.
3.6 Cell survival in isotonic media
The Isotonic media was composed of 8.5% (w/v) sucrose (Fisher) and 0.3%
(w/v) dextrose (Fisher) was used for preparing cell suspensions (Gascoyne et
al., 1997). The Dulbecco's Phosphate Buffered Saline (DPBS) (Invitrogen) was
used to adjust the conductivity of the isotonic media to 9 mS/cm (Labeed et al.,
2006). The viability of three cell lines in the 9 mS/cm conductivity isotonic media
was tested to ensure cells would survive in the media for at least 1 hour during
the impedance measurement. Cells in the isotonic media at 37°C are to mimic
the cells native growing environment. Figure 3.11 shows within 60 minutes,
three cell lines all can survive in the isotonic media.
3.7 Cell volume estimate
Because some cell lines had variable diameters, it was important to
determine cell volume (Figure 3.12). Before impedance measurement, the cell
volume of each cell line was measured by Packed Cell Volume counting tubes
(PCV tubes). 10µl of cell suspensions were loaded into a PCV tube and then
centrifuged at 5000rpm for 1 minute. The packed cell volume in µl can be read
from the PCV tubes (Figure 3.13).
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Cells were re-suspended at a density that resulted in them occupying 20%
of the volume with remaining 80% consisting of buffer. Figure 3.14 represents
the cell density at which 20% packed cell volume is generated, because the
small average diameters, MCF-10A cells were at density at 6X107 cells/ml.
However, the densities of MCF-7 and MDA-MB-231 cells were only around
3X107 cells/ml.
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Figure 3.10 Cell viability tests. Cells were incubated in buffer which is 50% DPBS and 50%
sterile water with 2% serum replacement for 0~60 minutes at 20°C. Cells were dyed with Trypan
Blue assay. The number of viable cells was determined using a haemocytometer in triplicate
from three wells and error bars represent standard deviation.
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Figure 3.11 Cell viability tests. Cells were incubated in isotonic media for 0~60 minutes at 37°C.
Cells were dyed with Trypan Blue assay. The number of viable cells was determined using a
haemocytometer in triplicate from three wells and error bars represent standard deviation.
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Figure 3.12 the standard curve of MCF-10A, MCF-7 and MDA-MB-231 packed cell volume with
corresponding cell density. The number of cells was determined by Trypan Blue Assay. 10µl of
cell suspensions in culture media were loaded into a PCV tube and then centrifuged at 5000rpm
for 1 minute. The packed cell volume in µl can be read from the PCV tubes. The X axis is cell
density; the Y axis is packed cell volume.
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Figure 3.13 the schematic of determine packed cell volume. (The picture with the asterisk was
from http://www.tpp-us.com/docs/products/pcv_biomass_cell_counters.html)
*
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Figure 3.14 cell density at 20% packed cell volume of each cell line. After trypsinization, 10µl
cell suspensions were loaded into a PCV tube and then centrifuged at 5000rpm for 1 minute.
The packed cell volume in µl can be read from the PCV tubes. Cells were re-suspended at a
density that resulted in them occupying 20% of the volume with remaining 80% consisting of
buffer. Error bars represent standard deviation.
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4 Bio-Impedance of cancer cell suspension for breast
cancer cell identification
4.1 Introduction
In this chapter, whether different pathologies of breast cancer cells can
be differentiated from breast tissue cells by Cell Impedance System (CIS) will
be investigated.
4.2 Bio-Impedance measurement process
Breast tissue cell line MCF-10A, early breast cancer cell line MCF-7 and
invasive breast cancer cell line MDA-MB-231 were cultured in several large
flasks until at around 70% confluence. After cells were in suspension by
trypsinization, cells were washed with DPBS and then removed. The modified
buffer, 50%DPBS and 50% sterile water with 2% serum replacement, or
isotonic media was used to re-suspend cells. Then cell suspensions were
loaded into chambers and cell density, packed cell volume (PCV) were detected
before and after each impedance measurement, as showed in Figure 4.1.
The cell impedance system was set up using an impedance analyser,
Agilent 4194A controlled by a laptop through a GPIB-USB cable for data
acquisition. The 4-terminal measurement device was plugged into the Agilent
4194A directly by four BNC connectors as shown in Figure 4.2. The 4-terminal
measurement device was composed of two parts: the cylindrical chamber and
the adapter. Two Platinum plated disc electrodes in the cylindrical chamber
provided the current and another two Platinum needle electrodes were used for
the voltage measurement. At the top of the cylindrical chamber, two holes were
made for loading cell suspension.
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Figure 4.1 the schematic of experiments: every breast cell line was removed from culture plates
by trypsinization, and then washed with DPBS and modified buffer or isotonic media,
respectively. Cells were re-suspended with modified buffer and loaded into the chamber
followed by cell density, packed cell volume and impedance measurement. (The picture with the
asterisk was from http://www.tpp-us.com/docs/products/pcv_biomass_cell_counters.html)
*
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Figure 4.2 Cell impedance system. Cell impedance system is composed of the cylindrical
chamber, the adapter with four BNC connectors and the impedance analyser controlled by a
computer.
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4.3 Cell density before and after each impedance
measurement
Before and after each impedance measurement, cell density was
measured to question whether cells were recovered. Figure 4.3 represents that
the density of MCF-10A cells reduced by around 42%. It could be due to cells
stuck onto the inner surface of the measurement cylindrical chamber or cell
death. However, cell density of MCF-7 and MDA-MB-231 were almost the same
as before impedance measurement. The small increase in cell density of MDA-
MB-231 is due to variation in the experiment. In the isotonic media, cell density
also varies in the three cell lines because of the same reason (Figure 4.4).
4.4 Electric model of cell suspension
In the study of cell impedance, a classic equivalent circuit model called
the Cole-Cole model is used to reveal the alteration of cells. Membrane
capacitance is an important electric property of cell membranes, where the
impedance decreases with increasing frequency (Cole and Cole, 1941). A pure
conductive solution shows a direct relationship between impedance and
frequency between 1 kHz to 10 MHz.
According to the electric equivalent model (Cole and Cole, 1941), at low
frequency (1kHz-20kHz) range the cell membrane performs as a pure resistor,
the Rm (Membrane resistance) as shown in Figure 4.5A and the total
measurement impedance is made up of Rb (Resistance from buffer) in the
parallel with the sum of Ri (intra-cellular resistance) and Rm. This arises over
low frequencies, with a small flow of current passed through cell membranes,
the impedance of membrane capacitance Cm is very high. So cell membranes
were considered as a good resistor and a part of current passed cell membrane
Rm and intracellular Ri; the other part of current went through buffer Rb directly.
Due to the frequency dependence of the membrane capacitance Cm,
when the frequency increases the membrane starts to be more conductive,
which makes the total impedance decrease (Cole and Cole, 1941). Over high
frequency range, greater than 1.5MHz, the membrane capacitance, Cm,
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becomes a good conductor over high frequencies, which little impedes the flow
of current and the capacitive impedance can be neglected compared to the
resistance of the membrane Rm. In this case, the entire impedance is
contributed only by the parallel combination of Rb and Ri.
Each type of cell has a specific combination of those parameters, Ri, Rm,
Cm, which has been treated as a unique signature of cells for the identification
of normal and cancer cells (Cole and Cole, 1941).
4.5 Bio-Impedance of breast cells
The impedance measurement of breast cell suspension were carried out
in two different conditions which were in 50%DPBS and 50% sterile water with 2%
serum replacement at 20°C, or in isotonic media at 37°C. The curve data shown
in Figure 4.5B and 4.5C were calibrated. The raw data were read directly from
the impedance analyser contained system errors. The calibration can remove
those system errors.
Figure 4.5B shows that in 50%DPBS and 50% sterile water with 2%
serum replacement at 20°C, normal breast cell line MCF-10A has lower
impedance than other two breast cancer cell lines over all frequencies. There
was no overlap between each cell line over low frequencies. The impedance of
MDA-MB-231 cells has large error bars may be due to variation in size. It was
clearly displayed that three cell lines can be differentiated by impedance. Over
the middle range of frequencies, the dispersion phenomenon is the drop of
impedance against frequency, thought to be caused by double layer structure of
cell membranes acting as an capacitor (Cole and Cole, 1941). The membrane
capacitance Cm was starting to become as a good conductor from a resistor as
illustrated before, which dominated the impedance changes.
Over low frequency of Figure 4.5B, 1 kHz~30 kHz 10 values of each cell
lines are used to calculate significance of the data. All the P Values are less
than 0.05, which means that there is significant difference among impedance of
three cell lines (Table 4.1). Membrane capacitance of each cell line also was
calculated as Table 4.2 shown. Cell impedance, cell diameter and packed cell
volume were very important factors in calculations. MCF-10A cells have highest
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membrane capacitance. MDA-MB-231 cells have lowest Cm among three cell
lines. The equations were provided by Dr Guofeng Qiao (Qiao, 2011).
Table 4.1 Student Ttest of 10 impedance values at low frequency (in modified buffer at 20°C)
Test P Value
MCF-10A against MCF-7 1.1E-15
MCF-10A against MDA-MB-231 2.5E-19
MCF-7 against MDA-MB-231 7.2E-18
Table 4.2 Membrane capacitance of cells from the equivalent circuit model (in modified buffer at
20°C)
Cm (µF/ cm2) SD
MCF-10A 3.0 0.4
MCF-7 1.1 0.1
MDA-MB-231 0.9 0.1
*The results were calculated from a series of equations which were provided by Dr Guofeng
Qiao (Qiao, 2011).
Figure 4.5C indicates that in the isotonic media at 37°C, normal breast
cell line MCF-7 has lower impedance than other two breast cancer cell lines at
all frequencies. MDA-MB-231 cells still have the highest impedance among
three cell lines. Also, the dispersion can be observed at middle range frequency.
Over low frequency of Figure 4.5C, 1 kHz~30 kHz 10 values of each cell
lines are used to calculate significance of the data. Though the error bars are
overlapping, all the P Values are still less than 0.05, which shows the significant
difference among impedance of three cell lines (Table 4.3). Membrane
capacitance of each cell line also was calculated as Table 4.4 shown. MCF-10A
cells have highest membrane capacitance. MCF-7 cells have lowest Cm among
three cell lines.
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Table 4.3 Student Ttest of 10 impedance values at low frequency (in isotonic media at 37°C)
Test P Value
MCF-10A against MCF-7 9.1E-18
MCF-10A against MDA-MB-231 7.5E-10
MCF-7 against MDA-MB-231 2.7E-16
Table 4.4 Membrane capacitance of cells from the equivalent circuit model (in isotonic media at
37°C)
Cm (µF/ cm2) SD
MCF-10A 4.3 0.2
MCF-7 3.7 0.5
MDA-MB-231 0.9 0.5
*The results were calculated from a series of equations which were provided by Dr Guofeng
Qiao (Qiao, 2011).
4.6 Transmission electron micrographs of breast cells
To investigate what may cause the impedance difference in different
pathologies of breast cells, the transmission electron micrographs were taken.
Figure 4.6 clearly show that MCF-10A cells had spherical nuclear envelope.
However, for MCF-7 cells nuclear envelope were not as circular as MCF-10A.
MDA-MB-231cells had nuclear envelope irregular.
The nuclear circularity of TEM photos of each cell line were analysed by
using the Image J software. The nuclear circularity of MDA-MB-231 had
significant difference compared to MCF-10A and MCF-7, respectively (Figure
4.7). Thanks Dr Julian Thorpe for the TEM section and TEM photographing.
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Figure 4.3 Cells viability test before or after four impedance measurement. Cells were incubated
in 50% DPBS and 50% sterile water with 2% serum replacement. Cell densities were measured
after each measurement.
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Figure 4.4 Cells viability test before or after four impedance measurement. Cells were incubated
in isotonic media. Cell densities were measured after each impedance measurement. Cell
densities were measured after each measurement.
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Figure 4.5 A is an electric equivalent circuit model for cell impedance analysis of a cell. Rb is the
resistance from buffer, Ri is the intra-cellular resistance. Rm and Cm are the membrane
resistance and capacitance, respectively. B represents that the impedance of four breast cells
lines measured using an Impedance Analyser at same volume ratio 20%(v/v) at 20°C. The
buffer is 50% sterile water and 50% DPBS with 2% serum replacement. C was measured in the
isotonic media at 37°C. X axis is frequency and Y axis is impedance. Error bars represent
standard deviation from four impedance measurements.
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Figure 4.6 Transmission electron micrographs of MCF-10A, MCF-7 and MDA-MB-231 cells.
Cells were removed from culture plates by trypsinization. The scale bar is 2 nm. Thanks Dr
Julian Thorpe for the TEM section and TEM photographing.
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Figure 4.7 Nuclear circularity of MCF-10A, MCF-7 and MDA-MB-231cells. The TEM
micrographs were analysed by using Image J. The circularity of a circle is 1. X axis is cell lines
and Y axis is nuclear circularity. The student Ttest as indicated (*,**) shows p value <0.05.
Error bars represent standard deviation.
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5 Bio-impedance of Jurkat 6 cell suspension for
apoptosis identification
5.1 Introduction
As described in Chapter Four, CIS can distinguish breast cancer cell
from breast tissue cells. Another question will be investigated in depth is
whether cell undergoing apoptosis and normal growing cells also can be
distinguished by CIS.
Cancer cells contain more apoptotic cells (Holland and Frei, 2000). The
application of chemotherapy reagent will induce cells apoptosis (Hannun, 1997).
To question whether cell impedance is able to differentiate cells apoptosis or
normal growth cells, Etoposide, a chemotherapy reagent, is used to induce
apoptosis (Kaufmann, 1989). It is widely used to treat many types of cancer
including breast cancer and lymphoma. In cell division, the topoisomerases II is
needed to unwind the DNA helix. The topoisomerases II can cut both strands of
the DNA helix. Cancer cells grow fast so they need more the topoisomerase II
than normal cells. Etoposide inhibits the topoisomerase II. If the topoisomerase
II is inhibited, cells stop dividing (Kellner et al., 2002) .
5.2 Fluorescent Activated Cell Sorting (FACS)
Four phases are consisted of cell cycle G1 phase, S phase, G2 phase
and M phase. In G1 phase, cells increase size and are ready for synthesis;
DNA replicate in S phase; Cells complete synthesis and are ready to divide in
G2 phase; in M phase, cells split.
Fluorescent activated cell sorting is a method to observe cell cycle profile
by a Flow cytometry. A distribution of cell in Sub G1, G1, S and G2 phase can
be plotted. Sub G1 is fractional DNA content, which are apoptotic cells. The
cleavage of chromosome DNA into fragments is one of the features of
apoptosis.
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DMSO treatment cells were measured as control cells as Etoposide is
dissolved in DMSO. Cells were analysed by a FACS CANTO flow cytometry
which shows DNA contents in cells. Figure 5.1 and Figure 5.2 shows that
compared with DMSO and Etoposide treated DG75 cells, from 24 hours cell
cycle changes occurred and more than 60% of cells accumulate in G2 phase.
Similarly, Figure 5.3 and Figure 5.4 represent that around 30% of Jurkat 6 cells
apoptosis. Etoposide induced DG 75 and Jurkat 6 cells apoptosis.
Different from lymphoma cells, with the same dose of Etoposide
treatment, cell cycle profile of G2 phase almost doubled as that at 0 hour time
point in MCF-10A cells (Figure 5.5 and Figure 5.6). Figure 5.7 and Figure 5.8
display that Etoposide did not influence MCF-7 cells. Around 25% cells
apoptosed in MDA-MB-231 cells and the percentage of cells in S phase
increased from 6.5% to 23.3% (Figure 5.9 and Figure 5.10). Etoposide can
slightly change cell cycle of breast cells
5.3 Using AlamarBlue Assay to indicate apoptosis
AlamarBlue Assay is another method to indicate cells apoptosis.
AlamarBlue is a proven indicator of cell viability. The living cells can reduce
resazurin to resorufin, the fluorescent molecule. The alamarBlue is a blue,
nontoxic, virtually non-fluorescent cell permeable compound. In the living cells,
resazurin is reduced to resorufin, which generates high intensity of red
fluorescence (LifeTechnologies, 2012). The higher florescent intensity indicates
healthy cells. The amount of resorufin decreased in cells apoptosis. So the
intensity of fluorescence declines.
After incubation with 10μL AlamarBlue for 5 hours, Jurkat 6 cells 
measured fluorescent intensity by using fluorometer (Promega GloMax-Multi
Detection System). The florescent intensity of DMSO treated Jurkat 6 cells
increased at 24 hours, which indicates cells were growing. However, there was
a dramatically drop in Etoposide treatment from 24 hours. Even at 72 hours the
florescent intensity cannot be observed as shown in Figure 5.11.
MCF-10A, MCF-7 and MDA-MB-231cells were trypsinazed and placed in
96-well plate at density of 2X105 cells/well. After added 10μL AlamarBlue, the 
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plate was incubated for 5 hours and then measured fluorescent intensity by
using fluorometer. Figure 5.12 shows that with the increasing time, the florescent
intensity of Etoposide groups were as high as control groups in all three cell
lines, which is unexpected.
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Figure 5.1 Effect of Etoposide on cell cycle profile of DG75 cells. Lymphoma cells DG75 were
treated with or without Etoposide, harvested at 0h, 24h, 48h and 72h and dyed by Propidium
Iodide (PI) Stain. Cells were analysed by FACS CANTO. The graphs show DNA changes in cell
cycle. The relative DNA content is shown on the X axis and the number of cells containing that
content on the Y axis. Cell with a G1 (P2), G2/ M (P3) or apoptotic content of DNA are shown.
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Figure 5.2 The histograms of FACS.results of DG75. X axis is cell cycle and Y axis is the
relative DNA content.
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Figure 5.3 Effect of Etoposide on cell cycle profile of Jurkat 6 cells. Lymphoma cells Jurkat 6
were treated with or without Etoposide, harvested at 0h, 24h, 48h and 72h and dyed by
Propidium Iodide (PI) Stain. Cells were analysed by FACS CANTO. The graphs show DNA
changes in cell cycle. The relative DNA content is shown on the X axis and the number of cells
containing that content on the Y axis. Cell with a G1 (P2), G2/M (P3) or apoptotic content of
DNA are shown.
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Figure 5.4 The histograms of FACS.results of Jurkat 6. X axis is cell cycle and Y axis is the
relative DNA content.
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Figure 5.5 Effect of Etoposide on cell cycle profile of MCF-10A cells. Breast tissue cells MCF-
10A were treated with or without Etoposide, harvested at 0h, 24h, 48h and 72h and dyed by
Propidium Iodide (PI) Stain. Cells were analysed by FACS CANTO. The graphs show DNA
changes in cell cycle. The relative DNA content is shown on the X axis and the number of cells
containing that content on the Y axis. Cell with a G1 (P2), G2/M (P3) or apoptotic content of
DNA are shown.
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Figure 5.6 The histograms of FACS.results of MCF-10A. X axis is cell cycle and Y axis is the
relative DNA content.
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Figure 5.7 Effect of Etoposide on cell cycle profile of MCF-7 cells. Breast cancer cells MCF-7
were treated with or without Etoposide, harvested at 0h, 24h, 48h and 72h and dyed by
Propidium Iodide (PI) Stain. Cells were analysed by FACS CANTO. The graphs show DNA
changes in cell cycle. The relative DNA content is shown on the X axis and the number of cells
containing that content on the Y axis. Cell with a G1 (P2), G2/M (P3) or apoptotic content of
DNA are shown.
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Figure 5.8 The histograms of FACS.results of MCF-7. X axis is cell cycle and Y axis is the
relative DNA content.
0h
24h
48h
72h
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
Cell cycle
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
Cell cycle
Etoposide - Etoposide +
68
Figure 5.9 Effect of Etoposide on cell cycle profile of MDA-MB-231 cells. Breast cancer cells
MDA-MB-231 were treated with or without Etoposide, harvested at 0h, 24h, 48h and 72h and
dyed by Propidium Iodide (PI) Stain. Cells were analysed by FACS CANTO. The graphs show
DNA changes in cell cycle. The relative DNA content is shown on the X axis and the number of
cells containing that content on the Y axis. Cell with a G1 (P2), G2/M (P3) or apoptotic content
of DNA are shown.
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Figure 5.10 The histograms of FACS.results of MDA-MB-231. X axis is cell cycle and Y axis is
the relative DNA content.
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
Cell cycle
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
0%
20%
40%
60%
80%
R
el
at
iv
e
D
N
A
co
nt
en
t
Cell cycle
0h
24h
48h
72h
Etoposide - Etoposide +
70
Figure 5.11 3X105 cells/ml of Jurkat 6 cells were either treated or untreated with Etoposide at
37°C. 100ml of cells were harvest at the indicate time point with 10μL of AlamarBlue incubated 
for 5 hours and then measured fluorescent intensity by using fluorometer with an excitation
wavelength of 560nm and an emission wavelength of 590nm. The fluorescence intensity of
blank control which was culture media with AlamarBlue was subtracted. Error bars represent
standard deviation.
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Figure 5.12 MCF-10A, MCF-7, and MDA-MB-231 cells were treated with trypsin. Cell
suspensions were placed at 96-well plate at density of 2X105 cells/ well with 10μL AlamarBlue 
incubated for 5 hours and then measured fluorescent intensity by using fluorometer with an
excitation wavelength of 560nm and an emission wavelength of 590nm. Error bars represent
standard deviation.
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Figure 5.13 Lysates were prepared from Jurkat 6 cells which were either treated or untreated
with Etoposide at each time point. Cell lysates were incubated with the Ac-DEVD-AMC
Caspase-3 Fluorogenic Substrate in a 96-well plate for 120 minutes. The caspase activity was
measured by fluorometer. Error bars represent standard deviation.
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Figure 5.14 Lysates were prepared from MCF-10A, MCF-7 and MDA-MB-231 cells which were
either treated or untreated with Etoposide at each time point. Cell lysates were incubated with
the Ac-DEVD-AMC Caspase-3 Fluorogenic Substrate in a 96-well plate for 120 minutes. The
caspase activity was measured by fluorometer with an excitation wavelength of 380nm and an
emission wavelength of 440nm. Error bars represent standard deviation.
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5.4 Using Caspase Assay to indicate apoptosis
Caspase proteins are very important in apoptosis. One major effector of
apoptosis is caspase-3. It is a cysteine protease which exists in cells as an
inactive precursor and can be activated by proteolytic processing. The activated
caspases can cleave downstream caspase proteins, pass and amplify the death
signals, and result in apoptosis (Cohen, 1997).
MCF-10A, MCF-7, and MDA-MB-231 cells after trypsinization and Jurkat
6 cells were lysed. The Ac-DEVD-AMC Caspase-3 assays were carried out in
96-well plate by mixing with lysed cells and then after incubated for 120 minutes.
The caspase activity was measured by the fluorometer. With the increasing time,
caspase 3 became active. Apoptosis was measured after 2 hours incubation. At
8 hours, Jurkat 6 cells apoptosis reached a peak as shown in Figure 5.13. But
in breast cell lines, caspase activities of Etoposide group were the same as the
control group with 24 hours treatment. No caspase activation was observed in
breast cell lines (Figure 5.14).
Table 5.1The effect of treatment of Etoposide on 5 cell lines:
DG75 Jurkat 6 MCF-10A MCF-7 MDA-MB-231
FACS Y Y Y N Y
AlamarBlue N/A Y N N N
Caspase 3 N/A Y N N N
N/A: Not applicable.
Etoposide is clearly causing apoptosis in Jurkat 6 cells (Table 5.1). For
the breast cells the data not so clear. Cell cycle changes have been observed
but no reduction in cell viability and no increase in caspase activity. Therefore,
analysis of apoptosis will be performed in Jurkat 6 cells.
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Figure 5.15 A shows that Jurkat 6 cells were either treated or untreated with Etoposide in time
course up to 48 hours at 37°C. The cell density was determined by Trypan Blue Assay at
indicated time point. B is the corresponding packed cell volume. 10µl of cell suspensions were
loaded into a PCV tube and then centrifuged at 5000rpm for 1 minute. The packed cell volume
in µl can be read from the PCV tubes.
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Figure 5.16 shows the average diameters of Jurkat 6 cells normal growing or undergoing
apoptosis. Jurkat 6 cells were either treated or untreated with Etoposide for 8 hours at 37°C.
The diameters of 25 cells of control or treatment were measured, respectively. Error bars
represent standard deviation.
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Figure 5.17 the standard curve of Jurkat 6 packed cell volume with corresponding cell density.
The number of Jurkat 6 cells was determined by Trypan Blue Assay. 10µl of cell suspensions in
culture media were loaded into a PCV tube and then centrifuged at 5000rpm for 1 minute. The
packed cell volume in µl can be read from the PCV tubes. The X axis is cell density; the Y axis
is packed cell volume.
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5.5 Cell density and diameter
As discussed in Chapter Four, cell survival and packed cell volume are
very important two factors in impedance measurement. But in apoptosis, cells
shrink and die in the end. It is ideal to find a time point in which cells undergo
apoptosis and cell size does not change a lot. As the caspase assay showed,
with 8 hours the treatment with Etoposide, Jurkat 6 cells were undergoing
apoptosis. Whether the cells are alive and whether cell size changes at 8 hours
need to be determined.
Jurkat 6 cells treatment with Etoposide in a time course and the viable
cells were determined with the Trypan blue assay. Figure 5.15A indicate that
the density of Etoposide treated cells started to decrease from 8 hour. At 48
hours, Jurkat 6 cells with Etoposide treatment did not survive. In the meantime,
cell volume was also measured by using PCV tubes. After 8 hours treatment,
the PCV of DMSO treated was kept on increasing due to cell proliferation, but
the PCV of Etoposide treated decreased as Figure 5.15B shown.
In order to know the cell diameters, 25 cells of each treatment were
measured under microscope by using IC Imaging Control 3.0 software. Figure
5.16 shows that at 8 hours treatment, cell diameters were the same and not
affected by the treatment. A series of packed cell volume at different density
had been determined to draw a standard curve in which 20% PCV
corresponding cell density can be read (Figure 5.17).
5.6 Bio-impedance of Jurkat 6 cells undergoing apoptosis
As described before, Jurkat 6 cells can survive in both modified buffer
which is 50% DPBS and 50% sterile with serum replacement and isotonic
media. It is still a question whether Jurkat 6 cells are able to survive after 8
hours treatment with DMSO or Etoposide in that media. Figure 5.18 represent
that over 60 minutes, Jurkat 6 cells with both treatments can survive in modified
buffer as well as isotonic media.
To prepare the impedance measurement, some samples of Jurkat 6 cell
with both treatments had been saved to verify if cells undergo apoptosis or not.
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As Figure 5.19 shown, the cells used to measure impedance were in
undergoing apoptosis.
Jurkat 6 cells with DMSO or Etoposide treatment were washed with
DPBS and removed. Cells were re-suspended with 50% DPBS and 50% sterile
water with 2% serum replacement or isotonic media. Before and after
measurement, viability, density testing and volume fraction were measured.
Each time, 180µL of cells suspension were loaded into a chamber.
The cell density before and after each impedance measurement were
also determined. Figure 5.20 shows that the cell density varies, because cells
were difficult to be removed completely from the cylindrical chamber after
impedance measurement.
In Figure 5.21, A shows cells were measured in modified buffer, the
Jurkat 6 cells undergoing apoptosis had higher impedance than normal growing
cells at all frequency and the dispersion appears from 0.5MHz to 1.5MHz. B
shows the same trends as A. But in isotonic media, the impedance difference
between cells undergoing apoptosis and normal was smaller.
Over low frequencies of Figure 5.21A and B, 1 kHz~30 kHz 10 values of
each cell lines are used to calculate significance of the data. Both of the P
Values are less than 0.05, which shows the significant (Table 5.2 and Table 5.4).
Membrane capacitance of each cell line also was calculated as Table 5.3 and
Table 5.5 shown (The equations were provided by Dr Guofeng Qiao). The
control group, DMSO, has higher membrane capacitance than the Etoposide
treated Jurkat 6 cells.
Table 5.2 Student Ttest of 10 impedance values at low frequency (in modified buffer at 20°C)
Test P Value
DMSO against Etoposide 9.9E-14
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Table 5.3 Membrane capacitance of Jurkat 6 cells from the equivalent circuit model (in modified
buffer at 20°C)
Cm (µF/ cm2) SD
DMSO 0.6 0.4
Etoposide 0.2 0.1
*The results were calculated from a series of equations which were provided by Dr Guofeng
Qiao (Qiao, 2011).
Table 5.4 Student Ttest of 10 impedance values at low frequency (in isotonic media at 37°C)
Test P Value
DMSO against Etoposide 8.5E-12
Table 5.5 Membrane capacitance of Jurkat 6 cells from the equivalent circuit model (in isotonic
media at 37°C)
Cm (µF/ cm2) SD
DMSO 0.8 0.1
Etoposide 0.6 0.02
*The results were calculated from a series of equations which were provided by Dr Guofeng
Qiao (Qiao, 2011).
5.7 Transmission electron micrographs of Jurkat 6 cells
Transmission electron micrographs were taken to investigate what
caused the impedance difference in undergoing apoptotic cells. After 8 hours,
chromosome condensation, cytoplasm bubbling and irregular cell shape
occurred in Etoposide treated Jurkat 6 cells in comparison with DMSO
treatment (Figure 5.22). Thanks Dr Julian Thorpe for the TEM section and TEM
photographing.
The nuclear circularity of TEM photos of cells were analysed using the
Image J software. The nuclear circularity and cell circularity of Jurkat 6 with
DMSO or Etoposide treatment for 8 hours had significant difference,
respectively (Figure 5.23).
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Figure 5.18 Jurkat 6 viability test. Lymphoma cells Jurkat 6 were either treated or untreated with
Etoposide for 8 hours at 37°C and incubated in 50% DPBS and 50% sterile water with 2%
Serum Replacement at 20°C (A) or 8mS isotonic media at 37°C (B) for 0~60 minutes. The
number of viable cells was determined by Trypan Blue Assay in triplicate. Error bars represent
standard deviation.
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Figure 5.19 Lysates were prepared from Jurkat 6 cells which were either treated or untreated
with Etoposide at each time point. Cell lysates were incubated with the Ac-DEVD-AMC
Caspase-3 Fluorogenic Substrate in a 96-well plate for 120 minutes. The caspase activity was
measured by fluorometer with an excitation wavelength of 380nm and an emission wavelength
of 440nm. Error bars represent standard deviation.
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Figure 5.20 Cells viability test before or after impedance measurement. Cells were incubated in
50%DPBS+50% sterile water, or the isotonic media. Cell densities were measured after each
impedance measurement
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Figure 5.21 the impedance of Jurkat 6 cell undergoing apoptosis measured using an Impedance
Analyser at same volume ratio 20%(v/v) at 20°C. Jurkat 6 cells were induced by Etoposide for 8
hours at 37°C. A The buffer is 50% sterile water and 50% DPBS with 2% serum replacement.
The conductivity is 8 mS. B the buffer is isotonic media and the conductivity is around 8 mS. X
axis is frequency and Y axis is impedance.
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Figure 5.22 Jurkat 6 cells undergoing apoptosis. Jurkat 6 cells were either treated or untreated
with Etoposide at 37°C. Transmission electron micrographs show the chromosome condensed
and vacuoles in cytoplasm in undergoing apoptosis. Thanks Dr Julian Thorpe for the TEM
section and TEM photographing.
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Figure 5.23 Nuclear circularity and cell circularity of Jurkat 6 cells. The TEM micrographs were
analysed by using Image J. The circularity of a circle is 1. X axis is control and treated Jurkat 6
cells and Y axis is nuclear circularity or cell circularity. The student Ttest as indicated (*,**)
shows p value <0.05. Error bars represent standard deviation.
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6 Discussion
Bio-impedance is a non-invasive, label-free, fast, low-cost way to be
applied to many fields as discussed before. In this study, with conditions
controlled, Cell Impedance System (CIS) has been successfully used to
distinguish the breast tissue cell line MCF-10A, the early-stage breast cancer
cell line MCF-7 and the invasive breast cancer cell line MDA-MB-231, and also
distinguish the lymphoma Jurkat 6 cells undergoing apoptosis and normal
growing.
In order to ensure the accurate results of cell impedance, the
measurement conditions were strictly controlled as discussed in Chapter Three.
The cell viability, cell volume, temperature, buffer conductivity these were
crucial factors which would affect the impedance measurement. In the
meanwhile, the system errors were minimized by two means. The calibration
solutions (Hanna Instruments, USA) with indicated conductivity were utilized to
calibrate the system before impedance measurement. Also, the system errors
generated by the impedance analyser can be eliminated by calculations (Qiao
et al., 2012).
There were two conditions we used to measure cell impedance, 50%
DPBS and 50% sterile water with 2% serum replacement at 25°C, and isotonic
media at 37°C. In both conditions, MCF-10A, MCF-7, MDA-MB-231, Jurkat 6
undergoing apoptosis, and Jurkat 6 cells all can survive over 120 minutes. This
ensured that during the impedance measurement cells were alive. Besides,
25°C was thought to be an ideal temperature which can keep cell survival and
prevent the over-heating generated by the flow of current. The research work of
Rodrigo Franco et al. on electronic impedance analysis of Jurkat apoptosis was
carried out at room temperature 20-25°C as well (Franco et al., 2008). And yet
the limitation is that it is not the temperature of native environment of cell
growing. Another limitation is that 50% DPBS and 50% sterile water with 2%
serum replacement is not isotonic media which may change the osmolality of
cells, though cells survived in it. Considering these limitations, isotonic media at
37°C is a better condition to mimic cell native growing environment.
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With respect to bio-impedance of cells, the work of Arum Han et al. on
quantification of breast cancer impedance spectroscopy (Han et al., 2007)
shows in the same order of impedance decreased with MCF-10A, MCF-7 and
MDA-MB-231. Also, the work of R. Pethig and M.S. Talary on dielectrophoretic
detection of Jurkat cells in undergoing Etoposide-induced apoptosis (Pethig and
Talary, 2007) shows the membrane capacitance of Jurkat undergoing apoptosis
was lower than the control group which is in the same trends of our search.
In the future, another issue that can be addressed is whether cancerous
cells surrounded with normal cells, will be apparent by CIS. This could be
tackled by mixing cell populations or perhaps the impedance properties of the
cancer cells could be modulated, for example by coating the cells with
antibodies carrying electrical conductors such as gold nano-particles.
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